These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 21362138)

  • 41. Mechanism and biological significance of CD44 cleavage.
    Nagano O; Saya H
    Cancer Sci; 2004 Dec; 95(12):930-5. PubMed ID: 15596040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyaluronan binding properties of a CD44 chimera containing the link module of TSG-6.
    Lesley J; English NM; Gál I; Mikecz K; Day AJ; Hyman R
    J Biol Chem; 2002 Jul; 277(29):26600-8. PubMed ID: 12011075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of CD44 splice variants in human primary brain tumors.
    Kaaijk P; Troost D; Morsink F; Keehnen RM; Leenstra S; Bosch DA; Pals ST
    J Neurooncol; 1995 Dec; 26(3):185-90. PubMed ID: 8750184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis.
    Bourrguignon LY; Iida N; Welsh CF; Zhu D; Krongrad A; Pasquale D
    J Neurooncol; 1995 Dec; 26(3):201-8. PubMed ID: 8750186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression.
    Khaldoyanidi S; Achtnich M; Hehlmann R; Zöller M
    Leuk Res; 1996 Oct; 20(10):839-51. PubMed ID: 8960109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of CD44 as a cell surface hyaluronan receptor during tumor invasion of connective tissue.
    Knudson W
    Front Biosci; 1998 Jul; 3():d604-15. PubMed ID: 9634543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion.
    Bourguignon LY; Singleton PA; Diedrich F; Stern R; Gilad E
    J Biol Chem; 2004 Jun; 279(26):26991-7007. PubMed ID: 15090545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.
    Bourguignon LY
    Semin Cancer Biol; 2008 Aug; 18(4):251-9. PubMed ID: 18450475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD44 and its partners in metastasis.
    Jothy S
    Clin Exp Metastasis; 2003; 20(3):195-201. PubMed ID: 12741678
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1.
    Dougherty GJ; Cooper DL; Memory JF; Chiu RK
    J Biol Chem; 1994 Mar; 269(12):9074-8. PubMed ID: 7510702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
    Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
    Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
    Bourguignon LY; Shiina M; Li JJ
    Adv Cancer Res; 2014; 123():255-75. PubMed ID: 25081533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD44 expression in metastatic and non-metastatic non-small cell lung cancers.
    Kargi HA; Kuyucuoğlu MF; Alakavuklar M; Akpinar O; Erk S
    Cancer Lett; 1997 Oct; 119(1):27-30. PubMed ID: 18372518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling.
    Hernández D; Miquel-Serra L; Docampo MJ; Marco-Ramell A; Cabrera J; Fabra A; Bassols A
    J Biol Chem; 2011 Jan; 286(2):1475-85. PubMed ID: 21078678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential expressions of CD44 variants in tumors affecting the central nervous system.
    Resnick DK; Resnick NM; Welch WC; Cooper DL
    Mol Diagn; 1999 Sep; 4(3):219-32. PubMed ID: 10553022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The interaction between CD44 on tumour cells and hyaluronan under physiologic flow conditions: implications for metastasis formation.
    Richter U; Wicklein D; Geleff S; Schumacher U
    Histochem Cell Biol; 2012 May; 137(5):687-95. PubMed ID: 22270319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD44 and the adhesion of neoplastic cells.
    Rudzki Z; Jothy S
    Mol Pathol; 1997 Apr; 50(2):57-71. PubMed ID: 9231152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD44 attenuates metastatic invasion during breast cancer progression.
    Lopez JI; Camenisch TD; Stevens MV; Sands BJ; McDonald J; Schroeder JA
    Cancer Res; 2005 Aug; 65(15):6755-63. PubMed ID: 16061657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.
    Ween MP; Oehler MK; Ricciardelli C
    Int J Mol Sci; 2011 Jan; 12(2):1009-29. PubMed ID: 21541039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.